Pharmaceutical Investing Deciphera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Pharmaceutical Investing EyePoint Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Ovid Therapeutics Announces Pricing of $30 Million of Securities in Concurrent Public Offerings of Common and Preferred Stock